Literature DB >> 17268611

Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs.

Georgina Estrada1, Elba Villegas, Gerardo Corzo.   

Abstract

Advances in NMR and mass spectrometry as well as in peptide biochemistry coupled to modern methods in electrophysiology have permitted the isolation and identification of numerous products from spider venoms, previously explored due to technical limitations. The chemical composition of spider venoms is diverse, ranging from low molecular weight organic compounds such as acylpolyamines to complex peptides. First, acylpolyamines (< 1000 Da) have an aromatic moiety linked to a hydrophilic lateral chain. They were characterized for the first time in spider venoms and are ligand-gated ion channel antagonists, which block mainly postsynaptic glutamate receptors in invertebrate and vertebrate nervous systems. Acylpolyamines represent the vast majority of organic components from the spider venom. Acylpolyamine analogues have proven to suppress hippocampal epileptic discharges. Moreover, acylpolyamines could suppress excitatory postsynaptic currents inducing Ca+ accumulation in neurons leading to protection against a brain ischemic insult. Second, short spider peptides (< 6000 Da) modulate ionic currents in Ca2+, Na+, or K+ voltage-gated ion channels. Such peptides may contain from three to four disulfide bridges. Some spider peptides act specifically to discriminate among Ca2+, Na+, or K+ ion channel subtypes. Their selective affinities for ion channel subfamilies are functional for mapping excitable cells. Furthermore, several of these peptides have proven to hyperpolarize peripheral neurons, which are associated with supplying sensation to the skin and skeletal muscles. Some spider N-type calcium ion channel blockers may be important for the treatment of chronic pain. A special group of spider peptides are the amphipathic and positively charged peptides. Their secondary structure is alpha-helical and they insert into the lipid cell membrane of eukaryotic or prokaryotic cells leading to the formation of pores and subsequently depolarizing the cell membrane. Acylpolyamines and peptides from spider venoms represent an interesting source of molecules for the design of novel pharmaceutical drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17268611     DOI: 10.1039/b603083c

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  33 in total

1.  Novel class of spider toxin: active principle from the yellow sac spider Cheiracanthium punctorium venom is a unique two-domain polypeptide.

Authors:  Alexander A Vassilevski; Irina M Fedorova; Ekaterina E Maleeva; Yuliya V Korolkova; Svetlana S Efimova; Olga V Samsonova; Ludmila V Schagina; Alexei V Feofanov; Lev G Magazanik; Eugene V Grishin
Journal:  J Biol Chem       Date:  2010-07-24       Impact factor: 5.157

2.  Unique bell-shaped voltage-dependent modulation of Na+ channel gating by novel insect-selective toxins from the spider Agelena orientalis.

Authors:  Bert Billen; Alexander Vassilevski; Anton Nikolsky; Sarah Debaveye; Jan Tytgat; Eugene Grishin
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

3.  Isolation, amino acid sequence and biological activities of novel long-chain polyamine-associated peptide toxins from the sponge Axinyssa aculeata.

Authors:  Satoko Matsunaga; Mitsuru Jimbo; Martin B Gill; L Leanne Lash-Van Wyhe; Michio Murata; Ken'ichi Nonomura; Geoffrey T Swanson; Ryuichi Sakai
Journal:  Chembiochem       Date:  2011-08-09       Impact factor: 3.164

Review 4.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

5.  Structure of membrane-active toxin from crab spider Heriaeus melloteei suggests parallel evolution of sodium channel gating modifiers in Araneomorphae and Mygalomorphae.

Authors:  Antonina A Berkut; Steve Peigneur; Mikhail Yu Myshkin; Alexander S Paramonov; Ekaterina N Lyukmanova; Alexander S Arseniev; Eugene V Grishin; Jan Tytgat; Zakhar O Shenkarev; Alexander A Vassilevski
Journal:  J Biol Chem       Date:  2014-10-28       Impact factor: 5.157

6.  The effect of spider toxin PhTx3-4, ω-conotoxins MVIIA and MVIIC on glutamate uptake and on capsaicin-induced glutamate release and [Ca2+]i in spinal cord synaptosomes.

Authors:  Jomara M Gonçaves; Juliano Ferreira; Marco Antonio M Prado; Marta N Cordeiro; Michael Richardson; Ana Cristina do Nascimento Pinheiro; Marco A Romano Silva; Celio José de Castro Junior; Alessandra H Souza; Marcus Vinicius Gomez
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

7.  The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.

Authors:  Raquel Tonello; Camilla Fusi; Serena Materazzi; Ilaria M Marone; Francesco De Logu; Silvia Benemei; Muryel C Gonçalves; Elisabetta Coppi; Celio J Castro-Junior; Marcus Vinicius Gomez; Pierangelo Geppetti; Juliano Ferreira; Romina Nassini
Journal:  Br J Pharmacol       Date:  2016-11-28       Impact factor: 8.739

Review 8.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009

9.  Molecular evolution, functional variation, and proposed nomenclature of the gene family that includes sphingomyelinase D in sicariid spider venoms.

Authors:  Greta J Binford; Melissa R Bodner; Matthew H J Cordes; Katherine L Baldwin; Melody R Rynerson; Scott N Burns; Pamela A Zobel-Thropp
Journal:  Mol Biol Evol       Date:  2008-11-28       Impact factor: 16.240

10.  Hydroxycinnamic acid amides from Scopolia tangutica inhibit the activity of M1 muscarinic acetylcholine receptor in vitro.

Authors:  Yan Zhang; Zhen Long; Zhimou Guo; Zhiwei Wang; Xiuli Zhang; Richard D Ye; Xinmiao Liang; Olivier Civelli
Journal:  Fitoterapia       Date:  2015-11-14       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.